SLXN
Biomotion Sciences Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.16M
P/E Ratio
—
EPS
$-8.96
Beta
0.06
52W High
$22.36
52W Low
$0.97
50-Day MA
$1.48
200-Day MA
$4.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biomotion Sciences Ordinary Shares
Biomotion Sciences (SLXN) is an innovative biotechnology firm specializing in regenerative medicine, dedicated to developing transformative therapies for severe and complex medical conditions. With a robust pipeline of promising product candidates, the company aims to significantly enhance patient outcomes and address unmet medical needs. Supported by strategic collaborations that bolster its research and development capabilities, Biomotion Sciences is well-positioned to thrive in the rapidly evolving biotechnology landscape, presenting a compelling investment opportunity for institutional investors seeking exposure to cutting-edge therapeutics.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-11.62M |
| Operating Margin | 0.00% |
| Return on Equity | -771.00% |
| Return on Assets | -144.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.83 |
| Price-to-Book | 1.63 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.07M |
| Float | $3.30M |
| % Insiders | 8.28% |
| % Institutions | 4.23% |
Historical Volatility
HV 10-Day
52.63%
HV 20-Day
95.69%
HV 30-Day
96.25%
HV 60-Day
88.80%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/16/2026